{"certainAgreement":{"otherDetails":"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:\n\n* The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or\n* The study has been completed at all study sites for at least 2 years","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Due to the early termination of the study, efficacy data were not available for all participants, and therefore the prespecified analyses were not conducted."},"pointOfContact":{"email":"ClinicalTrialDisclosures@gilead.com","organization":"Gilead Sciences","title":"Clinical Trial Disclosures"}}